Insiders who reported open-market trades in the last 12 months at the companies Saumya Sutaria files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Lisa Y. Foo - $8.97M in THC purchases and sales in the last 12 months
Thomas W. Arnst - $7.53M in THC purchases and sales in the last 12 months
Tammy Romo - $7.52M in THC purchases and sales in the last 12 months
R. Scott Ramsey - $4.60M in THC purchases and sales in the last 12 months
Paola M. Arbour - $4.20M in THC purchases and sales in the last 12 months
J. Robert Kerrey - $4.15M in THC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Saumya Sutaria is a corporate insider, tracked as CEO, Director of TENET HEALTHCARE CORP (THC). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Saumya Sutaria submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Saumya Sutaria been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($42.66M) across all tracked filings.
Saumya Sutaria is CEO, Director of TENET HEALTHCARE CORP (THC). 8 SEC Form 4 filings on record going back to 2025, most recently on 27 August 2026. Most recent open-market trade: sold $2.17M of THC on 27 August 2026. Lifetime open-market sales: $42.66M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Saumya Sutaria.
InsiderAlpha's records for Saumya Sutaria go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
